Center Updates
Tiny mineral particles are better vehicles for promising gene therapy
Dr. Bill Murphy and his group have engineered slow-release mRNA delivery therapies that work effectively to promote healing in mice.
July 1, 2020
New tool for assessing heart muscle cells helps unlock their potential
Dr. Wendy Crone and her team have created a new technique for coaxing immature cardiomyocytes to become mature cells with highly organized internal structures.
June 25, 2020
Honors: Jacques Galipeau, MD
Dr. Galipeau has begun his two year term serving as president-elect of the International Society for Cell & Gene Therapy (ISCT)…
June 12, 2020
Meyerand, Zumbrunnen named vice provosts; Cramer to continue in special role
Beth Meyerand, professor of medical physics and biomedical engineering, will become the vice provost for faculty and staff affairs starting July 21st…
June 9, 2020
Faculty receive WARF, Kellett, Romnes awards
Emery H. Bresnick, Gary Felsenfeld Professor of Cell and Regenerative Biology, is director of UW–Madison Blood Research Program and co-director of the Cancer Genetic/Epigenetic Mechanisms Program of the Carbone Cancer Center. His research led to the discovery of new paradigms of blood stem- and progenitor-cell development and function, as well as human disease diagnostic strategies.
May 12, 2020
Newly identified cellular trash removal program helps create new neurons
Assistant Professor of Neuroscience Darcie Moore led work with graduate student Christopher Morrow to discover how a cellular filament helps neural stem cells clear damaged and clumped proteins, an important step in eventually producing new neurons.
Feb. 27, 2020
Stem cells could help cancer patients fight dangerous infections
Scientists at the University of Wisconsin–Madison have developed a more efficient way to grow the white blood cells that serve as front-line defenders against bacterial infections but are often depleted as a potentially deadly side effect of cancer treatment.
Jan. 22, 2020
Flashing lights may provide vital first test of MS drug success
Measuring changes in the speed of electrical signals along nerves connecting the eyes to the brain may accurately reflect recovery from myelin loss in multiple sclerosis (MS), according to SCRMC faculty member Ian Duncan, and could be used to evaluate new treatments for the disease.
Dec. 16, 2019
